Vir Biotechnology

Details

  • Unternehmenstyp
    Globaler Konzern
About Vir Biotechnology

Vir Biotechnology, Inc. is a clinical‑stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. The company’s clinical‑stage portfolio includes programs for chronic hepatitis delta and multiple PRO‑XTEN® dual‑masked T‑cell engagers across validated targets in solid tumor indications.

Career Opportunities

Vir Biotechnology offers a dynamic working environment that fosters professional growth and collaboration among its employees. The company is committed to developing innovative therapies and provides opportunities for individuals to contribute to meaningful projects in the biopharmaceutical industry.

  • Collaborative work culture
  • Opportunities for professional development
  • Engagement in impactful healthcare solutions
>